Cargando…

Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study

PURPOSE: Telemedicine was rapidly implemented for initial consultations and radiation treatment planning in the wake of the coronavirus disease 2019 (COVID-19) pandemic. In this study, we explore utilization of and physician perspectives on this approach in an attempt to identify patient populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Helen, Cha, Elaine E., Lynch, Kathleen, Cahlon, Oren, Gomez, Daniel R., Shaverdian, Narek, Gillespie, Erin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462757/
https://www.ncbi.nlm.nih.gov/pubmed/32890525
http://dx.doi.org/10.1016/j.ijrobp.2020.07.007
_version_ 1783576983628677120
author Zhang, Helen
Cha, Elaine E.
Lynch, Kathleen
Cahlon, Oren
Gomez, Daniel R.
Shaverdian, Narek
Gillespie, Erin F.
author_facet Zhang, Helen
Cha, Elaine E.
Lynch, Kathleen
Cahlon, Oren
Gomez, Daniel R.
Shaverdian, Narek
Gillespie, Erin F.
author_sort Zhang, Helen
collection PubMed
description PURPOSE: Telemedicine was rapidly implemented for initial consultations and radiation treatment planning in the wake of the coronavirus disease 2019 (COVID-19) pandemic. In this study, we explore utilization of and physician perspectives on this approach in an attempt to identify patient populations that may benefit most from virtual care. METHODS AND MATERIALS: This is a mixed-methods study with a convergent design. Approximately 6 to 8 weeks after implementation of telemedicine, all radiation oncologists in a single academic radiation oncology department were invited to participate in either semistructured interviews with embedded survey questions or a concurrently administered survey only. Rapid qualitative analysis was used to identify common themes, and quantitative data was assessed using descriptive statistics and univariable analyses. RESULTS: At the apex of the pandemic, 92% of radiation oncology visits were conducted via telemedicine. In total, 51 of 61 radiation oncologists participated in the study (response rate 84%). Most (71%) reported no difference in ability to treat cancer appropriately via telemedicine, which was more common among specialized physicians (P = .01) but not those with higher visit volume or years of experience. Over half (55%) perceived no difference or even improvement in overall visit quality with telemedicine. Virtual visits were deemed acceptable for a median of 70% to 96% of patients, which varied by disease site. Need for physical examination, and availability of an acceptable proxy, factored into telemedicine acceptability. Most (88%) found telemedicine better than expected, but opinions were split on how telemedicine would affect physician burnout. Almost all (96%) foresaw a role for telemedicine beyond the pandemic and would opt for a median of 50% (interquartile range 20%-66%) of visits conducted via telemedicine. CONCLUSIONS: Among radiation oncologists in an academic setting, telemedicine was perceived to be highly appropriate and acceptable for most patients. Future studies should focus on identifying the 5% to 30% of patients whose care may be optimized with in-person visits, and if there is alignment with patient preferences.
format Online
Article
Text
id pubmed-7462757
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74627572020-09-02 Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study Zhang, Helen Cha, Elaine E. Lynch, Kathleen Cahlon, Oren Gomez, Daniel R. Shaverdian, Narek Gillespie, Erin F. Int J Radiat Oncol Biol Phys Telemedicine PURPOSE: Telemedicine was rapidly implemented for initial consultations and radiation treatment planning in the wake of the coronavirus disease 2019 (COVID-19) pandemic. In this study, we explore utilization of and physician perspectives on this approach in an attempt to identify patient populations that may benefit most from virtual care. METHODS AND MATERIALS: This is a mixed-methods study with a convergent design. Approximately 6 to 8 weeks after implementation of telemedicine, all radiation oncologists in a single academic radiation oncology department were invited to participate in either semistructured interviews with embedded survey questions or a concurrently administered survey only. Rapid qualitative analysis was used to identify common themes, and quantitative data was assessed using descriptive statistics and univariable analyses. RESULTS: At the apex of the pandemic, 92% of radiation oncology visits were conducted via telemedicine. In total, 51 of 61 radiation oncologists participated in the study (response rate 84%). Most (71%) reported no difference in ability to treat cancer appropriately via telemedicine, which was more common among specialized physicians (P = .01) but not those with higher visit volume or years of experience. Over half (55%) perceived no difference or even improvement in overall visit quality with telemedicine. Virtual visits were deemed acceptable for a median of 70% to 96% of patients, which varied by disease site. Need for physical examination, and availability of an acceptable proxy, factored into telemedicine acceptability. Most (88%) found telemedicine better than expected, but opinions were split on how telemedicine would affect physician burnout. Almost all (96%) foresaw a role for telemedicine beyond the pandemic and would opt for a median of 50% (interquartile range 20%-66%) of visits conducted via telemedicine. CONCLUSIONS: Among radiation oncologists in an academic setting, telemedicine was perceived to be highly appropriate and acceptable for most patients. Future studies should focus on identifying the 5% to 30% of patients whose care may be optimized with in-person visits, and if there is alignment with patient preferences. Elsevier Inc. 2020-10-01 2020-09-02 /pmc/articles/PMC7462757/ /pubmed/32890525 http://dx.doi.org/10.1016/j.ijrobp.2020.07.007 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Telemedicine
Zhang, Helen
Cha, Elaine E.
Lynch, Kathleen
Cahlon, Oren
Gomez, Daniel R.
Shaverdian, Narek
Gillespie, Erin F.
Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
title Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
title_full Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
title_fullStr Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
title_full_unstemmed Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
title_short Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
title_sort radiation oncologist perceptions of telemedicine from consultation to treatment planning: a mixed-methods study
topic Telemedicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462757/
https://www.ncbi.nlm.nih.gov/pubmed/32890525
http://dx.doi.org/10.1016/j.ijrobp.2020.07.007
work_keys_str_mv AT zhanghelen radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy
AT chaelainee radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy
AT lynchkathleen radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy
AT cahlonoren radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy
AT gomezdanielr radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy
AT shaverdiannarek radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy
AT gillespieerinf radiationoncologistperceptionsoftelemedicinefromconsultationtotreatmentplanningamixedmethodsstudy